In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regenerative Medicine Is Here: New Payment Models Key To Patient Access

Moving From Chronic Therapies To Cures - Creating A Pathway To Enable New Payment Models

Executive Summary

Potentially curative regenerative medicine therapies are no longer theoretical, but instead have become reality. As more and more gene, cell and tissue-based therapies reach the market, the need for payment solutions is becoming more pressing. The Alliance for Regenerative Medicine has consulted with payers and other stakeholders to consider the barriers to alternative payment models and look at possible solutions.

Advertisement

Related Content

US FDA Extends Payor Communications Safe Harbor To Off-Label Uses
CAR-T Reimbursement: Medicare Weighing Bundle For Kymriah, Yescarta In 2019
Orchard To Use Divested GSK Rare Disease Gene Therapies To Grow Globally
White Flag Raised: UniQure Gives Up On Glybera, But Not Gene Therapies
US Outcomes-Based Contracts: Big Uptick In Interest, But Not Execution
Cost Pushback Limiting Hepatitis C Drug Utilization

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV005371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel